Novavax shareholder Shah Capital to step back from activist role
Oct 16 (Reuters) — Shah Capital, one of Novavax's top shareholders, said on Friday it no longer seeks to influence control of the vaccine maker after restructuring into a family office. The investor has filed with the US Securities and Exchange Commission to voluntarily withdraw its registration as an investment advise